Testing for type-specific antibody to herpes simplex virus—implications for clinical practice
Clicks: 113
ID: 122004
2000
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
113 views
13 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #37 of 48 articles by views in journal of antimicrobial chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract. Recently, assays that can distinguish between antibody to herpes simplex virus (HSV) types 1 and 2 have become available. These tests not only make i
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (24 words).
Try re-searching for a better abstract.
| Reference Key |
m.2000journaltesting
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Cowan, F. M.; |
| Journal | journal of antimicrobial chemotherapy |
| Year | 2000 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.